Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Voyage81 is an Israeli deep-tech company that developed a software-based hyperspectral imaging platform. By utilizing advanced computer vision and AI algorithms, the company's technology allows standard RGB camera sensors to capture hyperspectral data, which can be used to identify material properties and biological characteristics. In the healthcare sector, this technology enables non-invasive monitoring of skin health, tissue oxygenation, and other physiological markers. The company was acquired by Apple in 2021 to integrate these advanced imaging capabilities into consumer hardware. This acquisition highlights the growing importance of computational photography and spectral analysis in both consumer and medical diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Voyage81.